The prospect for a soft landing and falling rates remain strong, but timing is still uncertain, notes Marc Pinto. He talks about how the focus on quality companies has proven to be a great strategy in uncertain periods. He also goes over opportunities in tech outside of the mega caps. He’s very positive on healthcare, biotech in particular.
Morning Trade Live
26 Jun 2024
SHARE